Testing a new marker for egg damage in women having IVF
Part of Women’s health & pregnancy clinical trials.
This trial studies a protein called CENP-V to see if it can help measure egg (oocyte) health. It includes women at different ages and those using frozen eggs, to find better ways to predict egg quality.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having controlled ovarian stimulation (egg retrieval) for IVF or egg freezing.
- You are between 18 and 45 years old.
- If you are 36–45, you have age-related infertility as the main reason for treatment.
- If you have frozen eggs, they were frozen using vitrification (not slow freezing).
- You do not have conditions like polycystic ovaries, endometriosis, or cancer that could affect egg quality.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new semi-automated system for freezing eggs (vitrification) to see if it works as well as the standard manual method. It involves egg donors and recipients undergoing IVF with donor eggs.
This study tests a new sensor to check the quality of eggs (oocytes) during IVF. It may help doctors choose the best eggs for fertilization.
This study tests a new way to mature eggs in the lab (called in vitro maturation) for women who want to preserve their fertility. It may help those who need egg retrieval but cannot use standard hormone stimulation.
This study tests a gentle egg maturation method (CAPA-IVM) for women who don't have PCOS and are doing their first IVF cycle. The goal is to see if it works well for freezing embryos for later transfer.
This study tests a way to mature eggs outside the body for women with PCOS or high ovarian reserve. It might help avoid side effects from fertility medications.
This study looks at how IVF hormone treatments affect the womb lining and whether they cause aging cells to build up. It may help doctors improve IVF success rates.
Hear when a new Establish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.